{"schema_version":"secwatch.filing_event.v1","accession":"0001140859-25-000081","form_type":"8-K","ticker":"COR","cik":"0001140859","company_name":"Cencora, Inc.","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.638510+00:00","generated_at":"2026-05-22T07:03:23.996289+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cencora Q2 FY2025 revenue $75.5B (+10.3% YoY); adj. EPS $4.42 (+16.3%); raises FY guidance","bullets":["Revenue $75.5B, +10.3% YoY; GAAP diluted EPS $3.68 vs $2.09 prior year.","Adjusted diluted EPS $4.42, up 16.3% from $3.80; adjusted net income $863M.","FY2025 adjusted diluted EPS guidance raised to $15.70-$15.95 from $15.30-$15.60.","CEO Robert Mauch highlights strength of value proposition and pharmaceutical distribution."],"urls":{"canonical":"https://secwatch.observer/filing/0001140859-25-000081","json":"https://secwatch.observer/filing/0001140859-25-000081.json","markdown":"https://secwatch.observer/filing/0001140859-25-000081.md","text":"https://secwatch.observer/filing/0001140859-25-000081.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1140859/000114085925000081/0001140859-25-000081-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1140859/000114085925000081/abc-20250507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T07:03:23.996289+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}